A novel apoptotic pathway in quiescent lymphocytes identified by inhibition of a post-proline cleaving aminodipeptidase: A candidate target protease, quiescent cell proline dipeptidase

Journal of Immunology

Volumn 163, Issue 6, 1999, Pages 3092-3099

  Chiravuri, Murali ^a   Schmitz, Tracy ^a   Yardley, Kurt ^a   Underwood, Robert ^a   Dayal, Yogeshwar ^a   Huber, Brigitte T ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPEPTIDASE; CASPASE; PROLINE DIPEPTIDASE; PROTEASOME;

APOPTOSIS; ARTICLE; CELL DEATH; CELL ULTRASTRUCTURE; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LYMPHOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION;

ANTIGENS, CD26; APOPTOSIS; BORONIC ACIDS; CASPASES; CELL DEATH; CYSTEINE ENDOPEPTIDASES; DIPEPTIDASES; ENZYME INHIBITORS; G0 PHASE; HUMANS; HYDROLYSIS; INTERPHASE; LYMPHOCYTES; MICROSCOPY, ELECTRON; MULTIENZYME COMPLEXES; PROLINE; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN PROCESSING, POST-TRANSLATIONAL; SUBSTRATE SPECIFICITY;

EID: 0033567998     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Jacobson, M. D., M. Weil, and M. C. Raff. 1997. Programmed cell death in animal development. Cell 88:347.
2. Wallach, D. 1997. Apoptosis: placing death under control. Nature 388:123.
3. Henkart, P. A. 1996. ICE family proteases: mediators of all apoptotic cell death? Immunity 4:195.
4. Osborne, B. A. 1996. Apoptosis and the maintenance of homeostasis in the immune system. Curr. Opin. Immunol. 8:245.
5. Denis, F., E. Rheaume, S. M. Aouad, A. Alam, R. P. Sekaly, and L. Y. Cohen. 1998. The role of caspases in T cell development and the control of immune responses. Cell. Mol. Life Sci. 54:1005.
6. Sarin, A., M. L. Wu, and P. A. Henkart. 1996. Different interleukin-1 β converting enzyme (ICE) family protease requirements for the apoptotic death of T lymphocytes triggered by diverse stimuli. J. Exp. Med. 184:2445.
7. Flentke, G. R., E. Munoz, B. T. Huber, A. G. Plaut, C. A. Kettner, and W. W. Bachovchin. 1991. Inhibition of dipeptidyl aminopeptidase IV (DP-IV) by Xaa-boroPro dipeptides and use of these inhibitors to examine the role of DP-IV in T-cell function. Proc. Natl. Acad. Sci. USA 88:1556.
8. Coutts, S. J., T. A. Kelly, R. J. Snow, C. A. Kennedy, R. W. Barton, J. Adams, D. A. Krolikowski, D. M. Freeman, S. J. Campbell, J. F. Ksiazek, et al. 1996. Structure-activity relationships of boronic acid inhibitors of dipeptidyl peptidase IV. I. Variation of the P2 position of Xaa-boroPro dipeptides. J. Med. Chem. 39:2087.
9. Lin, J., P. J. Toscano, and J. T. Welch. 1998. Inhibition of dipeptidyl peptidase IV by fluoroolefin-containing N-peptidyl-O-hydroxylamine peptidomimetics. Proc. Natl. Acad. Sci. USA 95:14020.
10. Underwood, R., M. Chiravuri, K. Yardley, H. Lee, T. Schmitz, and B. T. Huber. 1999. Sequence, purification and cloning of an intracellular serine protease, quiescent cell proline dipeptidase (QPP). J. Biol. Chem. In press.
11. Fenteany, G., R. F. Standaert, W. S. Lane, S. Choi, E. J. Corey, and S. L. Schreiber. 1995. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268:726.
12. Fenteany, G., and S. L. Schreiber. 1998. Lactacystin, proteasome function, and cell fate. J. Biol. Chem. 273:8545.
13. Wang, X., H. Luo, H. Chen, W. Duguid, and J. Wu. 1998. Role of proteasomes in T cell activation and proliferation. J. Immunol. 160:788.
14. Meriin, A. B., V. L. Gabai, J. Yaglom, V. I. Shifrin, and M. Y. Sherman. 1998. Proteasome inhibitors activate stress kinases and induce Hsp72: diverse effects on apoptosis. J. Biol. Chem. 273:6373.
15. Drexler, H. C. 1997. Activation of the cell death program by inhibition of proteasome function. Proc. Natl. Acad. Sci. USA 94:855.
16. Constam, D. B., A. R. Tobler, A. Rensing-Ehl, I. Kemler, L. B. Hersh, and A. Fontana. 1995. Puromycin-sensitive aminopeptidase: sequence analysis, expression, and functional characterization. J. Biol. Chem. 270:26931.
17. Ulmer, A. J., T. Mattern, A. C. Feller, E. Heymann, and H. D. Flad. 1990. CD26 antigen is a surface dipeptidyl peptidase IV (DPPIV) as characterized by monoclonal antibodies clone TII-19-4-7 and 4EL1C7. Scand. J. Immunol. 31:429.
18. Vivier, I., D. Marguet, P. Naquet, J. Bonicel, D. Black, C. X. Li, A. M. Bernard, J. P. Gorvel, and M. Pierres. 1991. Evidence that thymocyte-activating molecule is mouse CD26 (dipeptidyl peptidase IV). J. Immunol. 147:447.
19. Gutheil, W. G., and W. W. Bachovchin. 1993. Separation of L-Pro-DL-boroPro into its component diastereomers and kinetic analysis of their inhibition of dipeptidyl peptidase. IV. A new method for the analysis of slow, tight-binding inhibition. Biochemistry 32:8723.
20. Fadok, V. A., D. R. Voelker, P. A. Campbell, J. J. Cohen, D. L. Bratton, and P. M. Henson. 1992. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148:2207.
21. Martin, S. J., C. P. Reutelingsperger, A. J. McGahon, J. A. Rader, R. C. van Schie, D. M. LaFace, and D. R. Green. 1995. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med. 182:1545.
22. Zamzami, N., P. Marchetti, M. Castedo, C. Zanin, J. L. Vayssiere, P. X. Petit, and G. Kroemer. 1995. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J. Exp. Med. 181:1661.
23. Green, D. R., and J. C. Reed. 1998. Mitochondria and apoptosis. Science 281: 1309.
24. Wesch, D., S. Marx, and D. Kabelitz. 1998. Monocyte-dependent death of freshly isolated T lymphocytes: induction by phorbolester and mitogens and differential effects of catalase. J. Immunol. 161:1248.
25. Owen-Schaub, L. B., S. Yonehara, W. L. d. Crump, and E. A. Grimm. 1992. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell. Immunol. 140:197.
26. Miyawaki, T., T. Uehara, R. Nibu, T. Tsuji, A. Yachie, S. Yonehara, and N. Taniguchi. 1992. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J. Immunol. 149:3753.
27. Hallan, E., H. K. Blomhoff, E. B. Smeland, and J. Lomo. 1997. Involvement of ICE (Caspase) family in gamma-radiation-induced apoptosis of normal B lymphocytes. Scand. J. Immunol. 46:601.
28. Enari, M., H. Sakahira, H. Yokoyama, K. Okawa, A. Iwamatsu, and S. Nagata. 1998. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD [published erratum appears in Nature 1998 May · 28;393(6683): 396]. Nature 391:43.
29. Garcia-Calvo, M., E. P. Peterson, B. Leiting, R. Ruel, D. W. Nicholson, and N. A. Thornberry. 1998. Inhibition of human caspases by peptide-based and macromolecular inhibitors. J. Biol. Chem. 273:32608.
30. Vercammen, D., R. Beyaert, G. Denecker, V. Goossens, G. Van Loo, W. Declercq, J. Grooten, W. Fiers, and P. Vandenabeele. 1998. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J. Exp. Med. 187:1477.
31. Fuchs, E. J., K. A. McKenna, and A. Bedi. 1997. p53-dependent DNA damage-induced apoptosis requires Fas/APO-1-independent activation of CPP32β. Cancer Res. 57:2550.
32. Woo, M., R. Hakem, M. S. Soengas, G. S. Duncan, A. Shahinian, D. Kagi, A. Hakem, M. McCurrach, W. Khoo, S. A. Kaufman, et al. 1998. Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev. 12:806.
33. Atkinson, E. A., M. Barry. A. J. Darmon, I. Shostak, P. C. Turner, R. W. Moyer, and R. C. Bleackley. 1998. Cytotoxic T lymphocyte-assisted suicide: caspase 3 activation is primarily the result of the direct action of granzyme B. J. Biol. Chem. 273:21261.
34. Hirata, H., A. Takahashi, S. Kobayashi, S. Yonehara, H. Sawai, T. Okazaki, K. Yamamoto, and M. Sasada. 1998. Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis. J. Exp. Med. 187:587.
35. Grimm, L. M., A. L. Goldberg, G. G. Poirier, L. M. Schwartz, and B. A. Osborne. 1996. Proteasomes play an essential role in thymocyte apoptosis. EMBO J. 15: 3835.
36. Vanhoof, G., F. Goossens, I. De Meester, D. Hendriks, and S. Scharpe. 1995. Proline motifs in peptides and their biological processing. FASEB J. 9:736.
37. Kubota, T., G. R. Flentke, W. W. Bachovchin, and B. D. Stollar. 1992. Involvement of dipeptidyl peptidase IV in an in vivo immune response. Clin. Exp. Immunol. 89:192.
38. Bristol, L. A., W. Bachovchin, and L. Takacs. 1995. Inhibition of CD26 enzyme activity with pro-boropro stimulates rat granulocyte/macrophage colony formation and thymocyte proliferation in vitro. Blood 85:3602.
39. Jeanfavre, D. D., J. R. Woska, Jr., C. A. Pargellis, C. A. Kennedy, J. Prendergast, C. Stearns, P. L. Reilly, R. W. Barton, and B. J. Bormann. 1996. Effect of deoxycoformycin and Val-boroPro on the associated catalytic activities of lymphocyte CD26 and ecto-adenosine deaminase. Biochem. Pharmacol. 52:1757.
40. Welch, J. T., and J. Lin. 1996. Fluoroolefin containing dipeptide isosteres as inhibitors of dipeptidyl peptidase IV (CD26). Tetrahedron 52:291.
41. Wesselborg, S., O. Janssen, and D. Kabelitz. 1993. Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells. J. Immunol. 150:4338.
42. Cerwenka, A., H. Kovar, O. Majdic, and W. Holter. 1996. Fas- and activation-induced apoptosis are reduced in human T cells preactivated in the presence of TGF-β1. J. Immunol. 156:459.
43. Nishioka, W. K., and R. M. Welsh. 1994. Susceptibility to cytotoxic T lymphocyte-induced apoptosis is a function of the proliferative status of the target. J. Exp. Med. 179:769.
44. Tucek-Szabo, C. L., S. Andjelic, E. Lacy, K. B. Elkon, and J. Nikolic-Zugic. 1996. Surface T cell Fas receptor/CD95 regulation, in vivo activation, and apoptosis: activation-induced death can occur without Fas receptor. J. Immunol. 156: 192.
45. Oravecz, T., M. Pall, G. Roderiquez, M. D. Gorrell, M. Ditto, N. Y. Nguyen, R. Boykins, E. Unsworth, and M. A. Norcross. 1997. Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage. J. Exp. Med. 186:1865.
46. Shioda, T., H. Kato, Y. Ohnishi, K. Tashiro, M. Ikegawa, E. E. Nakayama, H. Hu, A. Kato, Y. Sakai, H. Liu, et al. 1998. Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1α (SDF-1α) and SDF-1β are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage. Proc. Natl. Acad. Sci. USA 95:6331.
47. Varshavsky, A. 1996. The N-end rule: functions, mysteries, uses. Proc. Natl. Acad. Sci. USA 93:12142.
48. Martin, S. J., and D. R. Green. 1995. Protease activation during apoptosis: death by a thousand cuts? Cell 82:349.
49. Margolin, N., S. A. Raybuck, K. P. Wilson, W. Chen, T. Fox, Y. Gu, and D. J. Livingston. 1997. Substrate and inhibitor specificity of interleukin-1β-converting enzyme and related caspases. J. Biol. Chem. 272:7223.
50. Talanian, R. V., C. Quinlan, S. Trautz, M. C. Hackett, J. A. Mankovich, D. Banach, T. Ghayur, K. D. Brady, and W. W. Wong. 1997. Substrate specificities of caspase family proteases. J. Biol. Chem. 272:9677.
51. Rock, K. L., C. Gramm, L. Rothstein, K. Clark, R. Stein, L. Dick, D. Hwang, and A. L. Goldberg. 1994. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78:761.
52. Lam, K. P., R. Kuhn, and K. Rajewsky. 1997. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 90:1073.
53. Kuo, C. T., M. L. Veselits, and J. M. Leiden. 1997. LKLF: a transcriptional regulator of single-positive T cell quiescence and survival. Science 277:1986.